Serum interleukin-12 levels in patients with multiple sclerosis

Neuroscience Letters

Volumn 251, Issue 2, 1998, Pages 129-132

  Drulovic J ^a   Mostarica Stojkovic M ^a   Levic Z ^a   Mesaros S ^a   Stojsavljevic N ^a   Popadic D ^a   Pravica, V ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Interleukin 12; Multiple sclerosis; Serum; Transforming growth factor ; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 12; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNOPATHOGENESIS; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0032563327     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00520-5     Document Type: Article

References (26)

1. Balashov, K.E., Smith, D.R., Khoury, S.J., Hafler, D.A. and Weiner, H.L., Increased interleukin-12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand, Proc. Natl. Acad. Sci. USA, 94 (1997) 599-603.
2. Becher, B., Dodelet, V., Fedorowicz, V. and Antel, J.P., Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro, J. Clin. Invest., 98 (1996) 1539-1543.
3. Bright, J.J., Musuro, B.F., Du, C. and Spiram, S., Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis, J. Neuroimmunol., 82 (1998) 22-30.
4. Drulović, J., Stojković-Mostarica, M., Lević, Z., Stojsavljević, N., Pravica, V. and Mesaroš, Š., Interleukin-12 and tumor necrosis factor-α levels in cerebrospinal fluid of multiple sclerosis patients, J. Neurol. Sci., 147 (1997) 145-150.
5. Drulović, J., Mostarica Stojković, M., Lević, Z., Stojsavljević, N., Pravica, V., Sokić, D. and Mesaroš, Š., Increased levels of TGF-β1 in cerebrospinal fluid of multiple sclerosis patients. In M. Lukić, M. Čolić, M. Mostarica-Stojković and K. Čuperlovic (Eds.), Immunoregulation in Health and Disease, Academic Press, London, 1997, pp. 311-316.
6. Dudley, D.J., Hunter, C., Mitchell, M.D., Varner, M.W. and Gately, M., Elevations of serum interleukin-12 concentrations in women with severe pre-eclampsia and HELLP syndrome, J. Reprod. Immunol., 31 (1996) 97-107.
7. Hendrzak, J.A. and Brunda, M.J., Interleukin 12. Biologic activity, therapeutic utility, and role in disease, Lab. Invest., 72 (1995) 619-637.
8. Issazadeh, S., Ljungdahl, A., Hojeberg, B., Mustafa, M. and Olsson, T., Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor-α and tumor necrosis factor-β, J. Neuroimmunol., 61 (1995) 205-212.
9. Kurtzke, J.F., Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 33 (1983) 1444-1452.
10. Leonard, J.P., Waldburger, K.E. and Goldman, S.J., Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12, J. Exp. Med., 181 (1995) 381-386.
11. Martin, R., McFarland, H.F. and McFarlin, D.E., Immunological aspects of demyelinating diseases, Annu. Rev. Immunol., 10 (1992) 153-187.
12. McCarron, R.M., Wang, L., Racke, M.K., McFarlin, D.E. and Spatz, M., Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells, J. Neuroimmunol., 43 (1993) 23-30.
13. Mokhtarian, F., Shi, Y., Shirazian, D., Morgante, L., Miller, A. and Grob, D., Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis, J. Immunol., 152 (1994) 6003-6010.
14. Moller, D.R., Wysocka, M., Greenlee, B.M., Ma, X., Wahl, L., Trinchieri, G. and Karp, C.L., Inhibition of human interleukin-12 production by pentoxiphylline, Immunology, 91 (1997) 197-203.
15. Nicoletti, F., Patti, F., Cocuzza, C., Zaccone, P., Nicoletti, A., Di Marco, R. and Reggio, A., Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis, J. Neuroimmunol., 70 (1996) 87-90.
16. Poser, C.M., Paty, D.W., Scheinberg, L., McDonald, W.I., Davis, F.A., Ebers, G.G., Johnson, K.P., Sibley, W.A., Silberberg, D.H. and Tourtellotte, W.W., New diagnostic criteria for multiple sclerosis: guidelines for research protocols, Ann. Neurol., 13 (1983) 27-31.
17. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Luer, W., Helwig, A. and Poser, S., Tumor necrosis factor-α messenger RNA expression in patients with relapsing remitting multiple sclerosis is associated with disease activity, Ann. Neurol., 37 (1995) 82-88.
18. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Luer, W. and Poser, S., Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis, Neurology, 44 (1994) 1523-1526.
19. Rieckmann, P., Weber, F., Gunther, A., Martin, S., Bitsch, A., Broocks, A., Kitze, B., Weber, T., Borner, T. and Poser, S., Pentoxiphylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis, J. Neuroimmunol., 64 (1996) 193-200.
20. Rosenberg, G.A., Estrada, E.Y., Dencoff, J.E. and Stetler-Stevenson, W.G., Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window, Brain. Res., 703 (1995) 151-155.
21. Selmaj, K.W. and Raine, C.S., Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro, Ann. Neurol., 23 (1988) 339-346.
22. Smith, T., Hewson, A.K., Kingsley, C.I., Leonard, J.P. and Cuzner, M.L., lnterleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rats, Am. J. Pathol., 150 (1997) 1909-1917.
23. Spuler, S., Yousry, T., Scheler, A., Voltz, R., Holler, E., Hartmann, M., Wick, M. and Hohlfeld, R., Multiple sclerosis: prospective analysis of TNF-α and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity, J. Neuroimmunol., 66 (1996) 57-64.
24. Tsukada, N., Miyagi, K., Matsuda, M., Yanagisawa, N. and Yone, K., Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis, J. Neurol. Sci., 102 (1991) 230-234.
25. Tsukamoto, T, Ishikawa, M. and Yamamoto, T., Suppressive effects of TNF-α on myelin formation in vitro, Acta Neurol. Scand., (1995) 71-75.
26. Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M.N., Cuzner, M.L. and Hafler, D.A., Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86) and interleukin-12 cytokine in multiple sclerosis lesions, J. Exp. Med., 182 (1995) 1985-1996.